Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis
Top Cited Papers
- 2 September 2000
- Vol. 321 (7260) , 531-535
- https://doi.org/10.1136/bmj.321.7260.531
Abstract
Objectives: To determine the benefits and harms of palliative chemotherapy in patients with locally advanced or metastatic colorectal cancer and to compare the outcomes for elderly and younger patients. Design: Meta-analysis of individual patient data and published summary statistics from trials for which individual patient data could not be obtained from the investigators. Studies: All randomised controlled trials comparing palliative chemotherapy with supportive care in patients with advanced colorectal cancer that were identified by computerised and hand searches of the literature, scanning references, and contacting investigators. Main outcome measures: Survival, disease progression, quality of life, and toxicity. Results: 13 randomised controlled trials including a total of 1365 patients met the inclusion criteria. Meta-analysis of seven trials that provided individual patient data (866 patients) showed that palliative chemotherapy was associated with a 35% reduction in the risk of death (95% confidence interval 24% to 44%). This translates into an absolute improvement in survival of 16% at both six and 12 months and an improvement in median survival of 3.7 months. No age related differences were found in the effectiveness of chemotherapy, but elderly patients were under represented in trials. The overall quality of evidence relating to treatment toxicity, symptom control, and quality of life was poor. Conclusions: Chemotherapy is effective in prolonging time to disease progression and survival in patients with advanced colorectal cancer. The survival benefit may be underestimated in this analysis as some patients in the control arms received chemotherapy.Keywords
This publication has 18 references indexed in Scilit:
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- Attitudes and practice in the management of metastatic colorectal cancer in BritainClinical Oncology, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical trialCancer, 1994
- Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastasesThe Lancet, 1994
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993
- General Condition of Asymptomatic Patients with Advanced Colorectal Cancer Receiving Palliative Chemotherapy: A longitudinal studyActa Oncologica, 1992
- Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastasesBritish Journal of Surgery, 1990
- Haematogenous metastastic patterns in colonic carcinoma: An analysis of 1541 necropsiesThe Journal of Pathology, 1986
- Chemotherapy after palliative resection of colorectal cancer. Yorkshire gastrointestinal tumour groupBritish Journal of Surgery, 1984